153 related articles for article (PubMed ID: 37715013)
1. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis.
Liu L; Zheng L; Liu S; Zhang M; Zhang S; Jiang Z; Qin C; Wang D
J Gastrointest Surg; 2023 Nov; 27(11):2297-2307. PubMed ID: 37715013
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis? - A propensity score matching study.
Zheng Y; Zhang J; Chen C; Gong Z; Wang Z; Deng Q; Yu S; Hu Y; Liu Y; Cao H; Xiao Q; Wang J; Ding K; Sun L
Eur J Surg Oncol; 2024 Feb; 50(2):107958. PubMed ID: 38219698
[TBL] [Abstract][Full Text] [Related]
4. Morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases with or without early postoperative intraperitoneal chemotherapy: A propensity score matched study.
Dranichnikov P; Graf W; Cashin PH
Eur J Surg Oncol; 2022 Jul; 48(7):1598-1605. PubMed ID: 35177313
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience.
Allievi N; Bianco F; Pisano M; Montori G; Fugazzola P; Coccolini F; Lotti M; Mosconi S; Merelli B; Campanati L; Lucianetti A; Ansaloni L; Magnone S
Updates Surg; 2023 Jan; 75(1):159-167. PubMed ID: 36371549
[TBL] [Abstract][Full Text] [Related]
6. [The safety and efficacy of prophylactic hyperthermic intraperitoneal chemotherapy for elderly patients with locally advanced gastric cancer: a propensity score matching analysis].
Yu T; Ma FH; An Q; Cao XL; Xiao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2867-2873. PubMed ID: 37726993
[No Abstract] [Full Text] [Related]
7. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
Langenbecks Arch Surg; 2021 Sep; 406(6):1847-1857. PubMed ID: 33704561
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
Yu P; Huang X; Huang L; Dai G; Xu Q; Fang J; Ye Z; Chai T; Du Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11491-11498. PubMed ID: 37392201
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis.
Patel M; Arora A; Mukherjee D; Mukherjee S
Int J Surg; 2023 Aug; 109(8):2435-2450. PubMed ID: 37158149
[TBL] [Abstract][Full Text] [Related]
10. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
Langenbecks Arch Surg; 2021 Jun; 406(4):1071-1080. PubMed ID: 33611693
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
12. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer.
Liu L; Sun L; Zhang N; Liao CG; Su H; Min J; Song Y; Yang X; Huang X; Chen D; Chen Y; Zhang HW; Zhang H
Int J Hyperthermia; 2022; 39(1):239-245. PubMed ID: 35100917
[TBL] [Abstract][Full Text] [Related]
13. Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases.
Steinhoff H; Acs M; Blaj S; Dank M; Herold M; Herold Z; Herzberg J; Sanchez-Velazquez P; Strate T; Szasz AM; Piso P
World J Gastroenterol; 2023 May; 29(18):2850-2863. PubMed ID: 37274066
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
15. Comparative Study of the Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer: A Propensity Score-Matching Analysis.
Shen C; Lin Y; Guo X; Li Y; Wang D; Du Z; Hu P; Chen X; Zeng X; Lv J; Wu C; Tao K
Ann Surg Oncol; 2022 Dec; 29(13):8551-8563. PubMed ID: 35941344
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
Grange R; Rousset P; Williet N; Guesnon M; Milot L; Passot G; Phelip JM; Le Roy B; Glehen O; Kepenekian V
Ann Surg Oncol; 2024 Apr; 31(4):2378-2390. PubMed ID: 38170409
[TBL] [Abstract][Full Text] [Related]
17. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
18. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
Zhou S; Jiang Y; Liang J; Pei W; Zhou Z
World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages.
Zhang JF; Lv L; Zhao S; Zhou Q; Jiang CG
Ann Surg Oncol; 2022 May; 29(5):3170-3186. PubMed ID: 35175455
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
Guo J; Deng Z; Jin L; Yin S; Xiong Z; Wang C; Chen H; Luo D; Huang D; Peng J; Chen S; Lian L
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17881-17896. PubMed ID: 37947869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
